AliveCor Inc (AliveCor) is a medical device and artificial intelligence company that develops and manufactures ECG hardware and software for mobile devices. The company provides Kardia, an AI-enabled platform to help clinicians manage patients for the detection of atrial fibrillation and normal sinus rhythm in an ECG. It offers KardiaMobile and KardiaBand applications. AliveCor provides portable devices, early detections, immediate feedback and convenient short-term and long-term self-monitoring solutions. The company offers key clinical validation studies that include arrhythmia assessment, early detection, post-ablation and post-surgery. AliveCor is headquartered in San Francisco, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company AliveCor Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- AliveCor Inc Company Overview
- AliveCor Inc Company Snapshot
- AliveCor Inc Pipeline Products and Ongoing Clinical Trials Overview
- AliveCor Inc - Pipeline Analysis Overview
- AliveCor Inc - Key Facts
- AliveCor Inc - Major Products and Services
- AliveCor Inc Pipeline Products by Development Stage
- AliveCor Inc Pipeline Products Overview
- KardiaK Software
- KardiaK Software Product Overview
- KardiaMobile - Anticoagulant Monitoring
- KardiaMobile - Anticoagulant Monitoring Product Overview
- KardiaMobile - EKG Interpretation
- KardiaMobile - EKG Interpretation Product Overview
- KardiaMobile - Heart Rate Variability (HRV)
- KardiaMobile - Heart Rate Variability (HRV) Product Overview
- KardiaMobile - Pediatric Patients
- KardiaMobile - Pediatric Patients Product Overview
- KardiaMobile - QT Interval Screening
- KardiaMobile - QT Interval Screening Product Overview
- KardiaMobile - ST Elevation Screening
- KardiaMobile - ST Elevation Screening Product Overview
- KardiaMobile Integrated With Theraxium DTx - Cardiotoxicity
- KardiaMobile Integrated With Theraxium DTx - Cardiotoxicity Product Overview
- AliveCor Inc - Key Competitors
- AliveCor Inc - Key Employees
- AliveCor Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- AliveCor Inc, Recent Developments
- Feb 07, 2024: Delve Health and AliveCor Collaborate to Revolutionize Digital Healthcare Solutions in Cardiology
- Nov 10, 2023: AliveCor Appoints Michael Rolla as Chief Revenue Officer, Enterprise
- Sep 26, 2023: AliveCor's KardiaMobile 6L Becomes First Personal ECG Device Recommended for Use in Psychiatric Services in England and Wales
- Jul 20, 2023: Alivecor and Thomas Jefferson University Hospital Partner to Evaluate Kardiamobile 6L for Qt Prolongation Screening in Patients Treated for Opioid Use Disorder
- May 19, 2023: PaceMate Announces announces first-in-market collaboration with AliveCor to offer the only remote cardiac remote monitoring platform to encompass consumer ECG, event monitoring, heart failure, and implantable cardiac devices
- Mar 03, 2023: GE HealthCare to Present Continuum of Care Innovations in Cardiology at ACC.23/WCC
- Dec 22, 2022: ITC rules Apple violated AliveCor’s patents
- Sep 28, 2022: AliveCor joins forces with Dignio to streamline the transfer of personal electrocardiogram data between patient and clinician
- Aug 12, 2022: NICE publishes first draft guidance from its Early Value Assessment pilot project recommending smartphone-linked ECG device
- Jun 27, 2022: ITC Administrative Law Judge finds Apple infringed AliveCor's patented technology
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- AliveCor Inc Pipeline Products and Ongoing Clinical Trials Overview
- AliveCor Inc Pipeline Products by Indication
- AliveCor Inc, Key Facts
- AliveCor Inc, Major Products and Services
- AliveCor Inc Number of Pipeline Products by Development Stage
- AliveCor Inc Pipeline Products Summary by Development Stage
- KardiaK Software - Product Status
- KardiaK Software - Product Description
- KardiaMobile - Anticoagulant Monitoring - Product Status
- KardiaMobile - Anticoagulant Monitoring - Product Description
- KardiaMobile - EKG Interpretation - Product Status
- KardiaMobile - EKG Interpretation - Product Description
- KardiaMobile - Heart Rate Variability (HRV) - Product Status
- KardiaMobile - Heart Rate Variability (HRV) - Product Description
- KardiaMobile - Pediatric Patients - Product Status
- KardiaMobile - Pediatric Patients - Product Description
- KardiaMobile - QT Interval Screening - Product Status
- KardiaMobile - QT Interval Screening - Product Description
- KardiaMobile - ST Elevation Screening - Product Status
- KardiaMobile - ST Elevation Screening - Product Description
- KardiaMobile Integrated With Theraxium DTx - Cardiotoxicity - Product Status
- KardiaMobile Integrated With Theraxium DTx - Cardiotoxicity - Product Description
- AliveCor Inc, Key Employees
- AliveCor Inc, Subsidiaries
- Glossary
- AliveCor Inc Pipeline Products by Equipment Type
- AliveCor Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Azumio Inc
- Qardio Inc
- ECG Scanning & Medical Services, Inc.
- Qardio Inc
- ECG Scanning & Medical Services, Inc.
- Azumio Inc
